CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474839948
- Phone
- 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-04 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +122,334 | $7.03 | $860K | 9,628,259 |
| 2023-01-04 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +58,369 | $7.80 | $455K | 9,686,628 |
| 2022-12-27 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +4,089 | $5.99 | $25K | 9,505,925 |
| 2022-12-19 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +98,787 | $5.90 | $583K | 9,501,836 |
| 2022-12-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +1,341,420 | $5.42 | $7.3M | 9,403,049 |
| 2022-12-15 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +237,029 | $5.50 | $1.3M | 8,061,629 |
| 2022-12-14 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +824,600 | $5.46 | $4.5M | 7,824,600 |
| 2022-12-13 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −2,000,000 | 1,962,202 | ||
| 2022-11-07 | Arroyo Santiago Chief Medical Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2022-08-09 | Hayes Melvin H. III Chief Operating Officer | Grant or award · Stock Option (right to buy) | +137,000 | 137,000 | ||
| 2022-08-09 | Oltmans Curtis Gale Chief Legal Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-07-15 | Tourangeau Greg Controller | Grant or award · Stock Option (right to buy) | +16,540 | 16,540 | ||
| 2022-06-28 | Ezekowitz Alan Director | Other disposition · Stock Option (right to buy) | −500 | 14,500 | ||
| 2022-06-27 | Ezekowitz Alan Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2022-06-27 | Gould Robert J Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2022-06-27 | Dorton Katina Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2022-06-27 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2022-06-27 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2022-06-27 | Banks Sonja Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2022-06-27 | Collins James J. Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 |
Page 5 of 7 · 136 trades